Table 5.
Outcome | Model | Estimate (SE) | OR (95% CI) | P value |
30-day mortality | CFS score (≥5) | 0.94 (0.20) | 2.55 (1.74 to 3.74) | <0.001* |
Urea (>7mmol/L) | 0.92 (0.19) | 2.50 (1.71 to 3.65) | <0.001* | |
Consolidation | 0.71 (0.24) | 2.04 (1.26 to 3.29) | 0.004* | |
Age (≥65 years) | 0.87 (0.21) | 2.39 (1.58 to 3.64) | <0.001* | |
FiO2 (>21) | 0.51 (0.18) | 1.67 (1.17 to 2.38) | 0.005* | |
Sex (male) | 0.43 (0.19) | 1.53 (1.06 to 2.22) | 0.023 | |
Respiratory rate (≥30 breaths/min) | 0.86 (0.22) | 2.36 (1.55 to 3.61) | <0.001 | |
72-hour mortality | CFS score (≥5) | 0.96 (0.34) | 2.60 (1.34 to 5.06) | 0.005 |
Urea (>7mmol/L) | 1.25 (0.43) | 3.50 (1.50 to 8.18) | 0.004 | |
Consolidation | 1.83 (0.74) | 6.21 (1.45 to 26.66) | 0.014 | |
Age (≥65 years) | 0.95 (0.45) | 2.59 (1.06 to 6.30) | 0.036 | |
SpO2 (≤94) | 0.90 (0.31) | 2.46 (1.34 to 4.51) | 0.004 | |
FiO2 (>21) | 1.13 (0.31) | 3.08 (1.67 to 5.68) | <0.001 |
CFS, Clinical Frailty Scale; FiO2, fraction of inspired oxygen; SpO2, oxygen saturation by pulse oximetry.